The largest database of trusted experimental protocols

Auto macs pro seperator and isolation kit

Manufactured by Miltenyi Biotec

The Auto MACS Pro Separator is a magnetic cell separation system designed for the automated and efficient isolation of specific cell populations from complex samples. The system utilizes magnetic beads coated with antibodies that bind to target cells, allowing for their separation and enrichment. The Auto MACS Pro Separator features a fully automated workflow, streamlining the cell isolation process and ensuring consistent, reproducible results.

Automatically generated - may contain errors

3 protocols using auto macs pro seperator and isolation kit

1

Hematopoietic Stem Cell Isolation and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All primary patient samples unless otherwise noted were collected under Biospecimen collection/banking study 09-141. The use of the samples for research purposes is covered under biospecimen research protocol 16-354. CD34+ HSPCs were purified from at least 5 or 10 mixed CB units (each unit from one healthy donor) in each purification. Mononuclear cells were first isolated from CB using Hespan and Ficoll-Hypaque Plus density centrifugation, followed by positive selection using the Auto MACS Pro Seperator and isolation Kit (Miltenyi). CD34+ cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM, Cellgro) 20% BIT 9500 medium (Stem Cell Technologies) supplemented with SCF (100 ng/ml), FLT-3 ligand (10 ng/ml), IL-6 (20 ng/ml) and TPO (100 ng/ml) as the basic culture. CD34+ cells were transduced with high-titer retroviral and lentiviral supernatant and 8μg/ml polybrene. To differentiate HSPCs, cells were cultured under the myeloid-promoting conditions: SCF (100 ng/ml), FLT-3 ligands (10 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml), GM-CSF (20 ng/ml) and G-CSF (20 ng/ml) and the erythroid-promoting conditions: Epo (6 IU/ml) and SCF (100 ng/ml). Cytokines were purchased from Peprotech, NJ.
+ Open protocol
+ Expand
2

Hematopoietic Stem Cell Isolation and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All primary patient samples unless otherwise noted were collected under Biospecimen collection/banking study 09-141. The use of the samples for research purposes is covered under biospecimen research protocol 16-354. CD34+ HSPCs were purified from at least 5 or 10 mixed CB units (each unit from one healthy donor) in each purification. Mononuclear cells were first isolated from CB using Hespan and Ficoll-Hypaque Plus density centrifugation, followed by positive selection using the Auto MACS Pro Seperator and isolation Kit (Miltenyi). CD34+ cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM, Cellgro) 20% BIT 9500 medium (Stem Cell Technologies) supplemented with SCF (100 ng/ml), FLT-3 ligand (10 ng/ml), IL-6 (20 ng/ml) and TPO (100 ng/ml) as the basic culture. CD34+ cells were transduced with high-titer retroviral and lentiviral supernatant and 8μg/ml polybrene. To differentiate HSPCs, cells were cultured under the myeloid-promoting conditions: SCF (100 ng/ml), FLT-3 ligands (10 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml), GM-CSF (20 ng/ml) and G-CSF (20 ng/ml) and the erythroid-promoting conditions: Epo (6 IU/ml) and SCF (100 ng/ml). Cytokines were purchased from Peprotech, NJ.
+ Open protocol
+ Expand
3

Expansion and Differentiation of HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ HSPCs were purified from at least 10 mixed CB units (each unit from one healthy donor) in each purification. After Hespan and Ficoll-Hypaque Plus density centrifugation, mononuclear cells from CB units were performed positive selection using the Auto MACS Pro Seperator and isolation Kit (Miltenyi). CD34+ cells were cultured in basic medium containing Iscove’s modified Dulbecco’s medium (IMDM, Cellgro) 20% BIT 9500 medium (Stem Cell Technologies) supplemented with SCF (100 ng/ml), FLT-3 ligand (10 ng/ml), IL-6 (20 ng/ml) and TPO (100 ng/ml). To differentiate HSPCs, cells were cultured under the myeloid-promoting conditions: SCF (100 ng/ml), FLT-3 ligands (10 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml), GM-CSF (20 ng/ml) and G-CSF (20 ng/ml) or the erythroid-promoting conditions: Epo (6 IU/ml) and SCF (100 ng/ml). Cytokines were purchased from Peprotech, NJ.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!